Table 2.
Volunteernumbersex/age (Y) | I* | II | III | IV | IV/II ratio | |
---|---|---|---|---|---|---|
1 F/37 | 0.00 | 195.12 | 0.00 | 393.47 | 2.02 | |
2 F/39 | 0.00 | 340.90 | 0.00 | 513.09 | 1.51 | |
3 F/43 | 2.68 | 327.62 | 8.96 | 631.82 | 1.93 | |
4 M/35 | 4.72 | 656.32 | 0.00 | 1108.74 | 1.69 | |
5 F/48 | 9.42 | 643.83 | 0.00 | 1166.94 | 1.81 | |
6 F/22 | 0.00 | 859.50 | 61.34 | 1266.66 | 1.47 | |
7 F/27 | 30.81 | 738.69 | 0.00 | 1952.90 | 2.64 | |
8 F/29 | 11.75 | 1310.00 | 42.72 | 2178.76 | 1.66 | |
9 F/35 | 0.00 | 1310.14 | 29.69 | 3010.13 | 2.30 | |
10 F/31 | 0.00 | 1532.17 | 9.79 | 3426.37 | 2.24 | |
11 M/23 | 3.05 | 3872.72 | 3.05 | 5403.99 | 1.40 | |
Mean ± SD | 5.68 ± 9.28 | 1071.55 ± 1026.60 | 14.14 ± 21.11 | 1913.90 ± 1525.93 | 1.88 ± 0.39 | |
The data are shown in order of increasing IFN-α concentration.
I*; Control, II; CpG alone, III; IL-29 alone and IV; Both CpG and IL-29. There was a statistically significant increase in IFN-α secretion in culture condition IV compared with culture condition II (p=0.003, Wilcoxon signed rank test).